EIGHTCO HOLDINGS INC. ANNOUNCES DATE OF FOURTH QUARTER 2022 EARNINGS RELEASE AND OPERATIONAL UPDATE
06 avr. 2023 07h30 HE
|
Eightco Holdings Inc.
SAFETY HARBOR, Florida, April 06, 2023 (GLOBE NEWSWIRE) -- Eightco Holdings Inc., a publicly-traded company listed on NASDAQ under the ticker symbol OCTO, is pleased to announce that it will be...
Healthier Choices Management Corp. Reports Fourth Quarter 2022 Financial Results and Full Year Fiscal 2022 Results
03 avr. 2023 08h30 HE
|
Healthier Choices Management Corp
-Fourth Quarter Sales of $12.3 Million, Up 285%, and Gross Profit of $4.0M Up 321%, over Q4 2021 -Full Year Sales of $29.3 Million, Up 120%, and Gross Profit of $10.2 Million Up 93%; over 2021 ...
DIGITAL ALLY SETS DATE TO ANNOUNCE FOURTH QUARTER 2022 AND YEAR-END OPERATING RESULTS
30 mars 2023 08h20 HE
|
Digital Ally, Inc.
Digital Ally to Discuss Year-End Results, Status of Previously Announced Corporate Spin-Off, and Individual Subsidiary Outlooks. KANSAS CITY, March 30, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc....
Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business Results
27 mars 2023 16h05 HE
|
Interpace Biosciences, Inc.
●Q4 Revenue of $8.3 million ●Cash and Cash Equivalents total $4.8 million as of December 31, 2022 PARSIPPANY, NJ, March 27, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or...
OMNIQ SCHEDULES FOURTH QUARTER 2022 AND FULL YEAR 2022 EARNINGS RELEASE AFTER THE MARKET CLOSE ON THURSDAY, MARCH 30TH 2023.
24 mars 2023 08h45 HE
|
OMNIQ Corp.
SALT LAKE CITY, March 24, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) a provider of Artificial Intelligence (AI)-based solutions, will release Fourth Quarter 2022 and Full Year 2022 Earnings...
IMUNON to Hold Fourth Quarter 2022 Financial Results and Business Update Conference Call on Thursday, March 30, 2023
23 mars 2023 08h30 HE
|
Imunon, Inc.
LAWRENCEVILLE, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
SuRo Capital Corp. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Wednesday, March 15, 2023
08 mars 2023 16h05 HE
|
SuRo Capital Corp.
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter and fiscal year ended...
Magna Announces Fourth Quarter 2022 Results and 2023 Outlook
10 févr. 2023 05h00 HE
|
Magna International Inc.
Fourth Quarter 2022 Highlights Sales increased 5% to $9.6 billionExcluding foreign currency translation sales increased 13%, compared to a global light vehicle production increase of 5%Diluted...
First Bank Reports Fourth Quarter 2022 Net Income of $9.1 Million and Full Year Net Income of $36.3 Million
25 janv. 2023 16h33 HE
|
First Bank
HAMILTON, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) today announced results for the fourth quarter and full year 2022. Net income for the fourth quarter of 2022...
SuRo Capital Corp. Fourth Quarter and Fiscal Year 2022 Preliminary Investment Portfolio Update
17 janv. 2023 08h00 HE
|
SuRo Capital Corp.
NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its investment...